Nicardipine use in cerebrovascular disease: A review of controlled clinical studies

Journal of the Neurological Sciences

Volumn 283, Issue 1-2, 2009, Pages 219-223

  Amenta, Francesco ^a   Lanari, Alessia ^b   Mignini, Fiorenzo ^a   Silvestrelli, Giorgio ^b   Traini, Enea ^a   Tomassoni, Daniele ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

Author keywords

Hypertension; Nicardipine; Stroke; Subarachnoid haemorrhage; Vascular cognitive impairment; Vascular dementia

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIHYDROPYRIDINE DERIVATIVE; FIBRINOLYTIC AGENT; LABETALOL; NICARDIPINE; PLACEBO;

ALZHEIMER DISEASE; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; BRAIN FUNCTION; BRAIN PERFUSION; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG IMPLANT; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; GERIATRIC PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; MEMORY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PRIORITY JOURNAL; RATING SCALE; RISK REDUCTION; SANDOZ CLINICAL ASSESSMENT GERIATRIC SCALE; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR DISORDERS; COGNITION; COGNITION DISORDERS; CONTROLLED CLINICAL TRIALS AS TOPIC; DEMENTIA, VASCULAR; HUMANS; NICARDIPINE; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 67650169053     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.02.335     Document Type: Article

References (66)

1. Liebson P.R. Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother 7 (2006) 2385-2401
2. Eisenberg M.J., Brox A., and Bestawros A.N. Calcium channel blockers: an update. Am J Med 116 (2004) 35-43
3. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25 (2007) 1751-1762
4. Messerli F.H., Williams B., and Ritz E. Essential hypertension. Lancet 370 (2007) 591-603
5. Epstein B.J., Vogel K., and Palmer B.F. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 67 (2007) 1309-1327
6. Rinkel G.J.E., Feigin V.L., Algra A., van den Bergh W.M., Vermeulen M., and van Gijn J. Calcium antagonists for aneurismal subarachnoid haemorrhage. Cochrane Database Syst Rev 1 (2005) CD000277
7. Sabbatini M., Strocchi P., and Amenta F. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders. Clin Exp Hypertens 17 (1995) 719-750
8. Liu-Deryke X., and Rhoney D.H. Cerebral vasospasm after aneurismal subarachnoid haemorrhage: an overview of pharmacologic management. Pharmacotherapy 26 (2006) 182-203
9. Stippler M., Crago E., Levy E.I., Kerr M.E., Yonas H., Horowitz M.B., et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid haemorrhage. Neurosurg 105 (2006) 723-729
10. Flamm E.S., Adams H.P., Beck D.W., Pinto R.S., Marler J.R., Walker M.D., et al. Dose-escalation study of intravenous nicardipine in patients with aneurismal subarachnoid haemorrhage. J Nerosurg 68 (1988) 393-400
11. Montarry M., Chacornac R., Philippon B., Bouchet C.I., and Guichard P. Effects of an intravenous injection of nicardipine on cerebral blood flow in subarachnoid haemorrhage caused by intracranial aneurysm. Agressologie 30 (1989) 411-415
12. Combes P., and Fauvage B. Systemic vasomotor interaction between nicardipine and hypocapnic alkalosis in man. Intensive Care Med 18 (1992) 89-92
13. Beck D.W., Adams H.P., Flamm E.S., Godersky J.C., and Loftus C.M. Combination of aminocaproic acid and nicardipine in treatment of aneurismal subarachnoid haemorrhage. Stroke 19 (1988) 63-67
14. Fujita K., Yamashita H., Masamura M., Ehara K., Tamaki N., and Matsumoto S. The effects of ticlopidine and nicardipine on the prevention of symptomatic vasospasm after aneurismal rupture. No Shinkei Geka (Jap) 16 (1988) 741-746
15. Haley Jr. E.C., Kassell N.F., and Torner J.C. A randomized controlled trial of high-dose intravenous nicardipine in aneurismal subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78 (1993) 537-547
16. Haley Jr. E.C., Kassell N.F., and Torner J.C. A randomized trial of nicardipine in subarachnoid haemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78 (1993) 548-553
17. Haley Jr. E.C., Kassell N.F., Torner J.C., Truskowski L.L., and Germanson T.P. A randomized trial of two doses of nicardipine in aneurismal subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80 (1994) 788-796
18. Feigin V.L., Rinkel G.J., Algra A., Vermeulen M., and van Gijn J. Calcium antagonists for aneurismal subarachnoid haemorrhage. Cochrane Database Syst Rev 2 (2000) CD000277
19. Badjatia N., Topcuoglu M.A., Pryor J.C., Rabinov J.D., Ogilvy C.S., Carter B.S., et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25 (2004) 819-826
20. Avitsian R., Fiorella D., Soliman M.M., and Mascha E. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series. J Neurosurg Anesthesiol 19 (2007) 125-129
21. Tejada J.G., Taylor R.A., Ugurel M.S., Hayakawa M., Lee S.K., and Chaloupka J.C. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid haemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 28 (2007) 844-848
22. Kasuya H., Onda H., Takeshita M., Okada Y., and Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33 (2002) 1011-1015
23. Kasuya H., Onda H., Sasahara A., Takeshita M., and Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid haemorrhage. Neurosurgery 56 (2005) 895-902
24. Barth M., Capelle H.H., Weidauer S., Weiss C., Munch E., Thome C., et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurismal subarachnoid haemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38 (2007) 330-336
25. Krischek B., Kasuya H., Onda H., and Hori T. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid haemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 47 (2007) 389-394
26. Medical Reseach Council Working Party. Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Br Med J 296 (1988) 1565-1570
27. Barry D.I., Vorstrup S., Jarden J.O., Svendsen U.G., Braendstrup O., Graham D.I., et al. Effects of antihypertensive drugs on the cerebral circulation. Acta Med Scand 677 (1993) 143-147
28. Inzitari D., and Poggesi A. Calcium channel blockers and stroke. Aging Clin Exp Res 17 (2005) 16-30
29. Martì Masso J.F., and Lozano R. Nicardipine in the prevention of cerebral infarction. Clin Ther 12 (1990) 344-351
30. Lozano R., and Balaguer A. Nicardipine in the treatment of outpatients with cerebrovascular disorders. Clin Ther 13 (1991) 496-499
31. Ribas Mundò M., and Lozano R. The influence of nicardipine in patients with high risk of stroke. J Cardiovasc Pharmacol 16 (1990) S16-S19
32. Yao L.P., and Ding D.Y. Effect of nicardipine on somatosensory evoked potentials in patients with acute cerebral infarction. J Neurol Neurosurg Psychiatry 53 (1990) 844-846
33. Rosenbaum D.M., Zabramski J., Frey J., Yatsu F., Marler L., Spetzler R., et al. Early treatment of ischemic stroke with a calcium antagonist. Stroke 22 (1991) 437-441
34. Lisk D.R., Grotta G.C., Lamki L.M., Tran H.D., Taylor J.W., Molony D.A., et al. Should hypertension be treated after acute stroke?. Arch Neurol 50 (1993) 855-862
35. Uematsu D., Watanabe S., and Katayama T. Nicardipine improves cerebral hemodynamics in acute and subacute stroke. Neurology 42 Suppl 3 (1992) 395
36. Gamèz N.M., Soto Mas J.A., Aguilar Martinez J.L., Bermùdez Garcia J.M., Salim A., Ramos Jimènez A., et al. Ensayo clìnico controlado a doble ciego: nicardipina frente a placebo en la isquemia cerebral focal aguda. Med Clin (Barc) 90 (1988) 690-692
37. Shah Q.A., Georgiadis A., Suri M.F., Rodriguez G., and Qureshi A.I. Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke. Neurocrit Care 7 (2007) 53-57
38. Liu-Deryke X., Janisse J., Coplin W.M., Parker Jr. D., Norris G., and Rhoney D.H. A Comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care 9 (2008) 167-176
39. Guo Z., Viitanen M., Fratiglioni L., and Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 312 (1996) 805-808
40. Glynn R.J., Beckett L.A., Hebert L.E., et al. Current and remote blood pressure and cognitive decline. JAMA 281 (1999) 438-445
41. Eftekhari H., Uretsky S., and Messerli F.H. Blood pressure, cognitive dysfunction and dementia. J Am Soc Hypertens 1 (2007) 135-144
42. Staessen J.A., Richart T., and Birkenhäger W.H. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 49 (2007) 389-400
43. Amenta F., Mignini F., Rabbia F., Tomassoni D., and Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci 203-204 (2002) 147-151
44. Handa J., Matsuda M., Nakasu Y., Nakasu S., Kidooka M., and Watanbe K. Clinical effect of a new 1,4-dihydropyridine derivative, YC-93, in patients with cerebrovascular diseases. Arch Jpn Chir 48 (1979) 400-403
45. Miyamoto T. Effect of long-term treatment with YC-93 (nicardipine HCl), a 1,4,-dihydropyridine derivative, on obstructive cerebrovascular disorders. Clin Rep (Jap) 15 (1981) 426-434
46. Saku J. Clinical use of YC-93 (nicardipine HCl) in patients with cerebrovascular disorders. Part 2. Long-term use of YC-93. Clin Rep (Jap) 15 (1981) 233-242
47. Tajika Y. Clinical study of nicardipine hydrochloride (Perdipine) in patients with cerebral vascular disorders. Basic Clin Med (Jap) 16 (1982) 315-318
48. Tamura M. Clinical efficacy of nicardipine hydrochloride for the treatment of various cerebrovascular disorders. Clin Rep (Jap) 16 (1982) 257-262
49. Hiramine T. Clinical effects of nicardipine hydrochloride (perdipine) on cerebrovascular disorders. Med Consult New Remed (Jap) 20 (1983) 97-102
50. Kuriyama Y., Sawada T., Niimi T., Naritomi H., Kinugawa H., Fukushima M., et al. Effects of nicardipine and nifedipine on cerebral circulation in cerebrovascular disorders. J Cereb Blood Flow Met 3 Suppl 1 (1983) 560-561
51. Iijima K. Effects of perdipine on post apoplectic disorders and cerebral arteriosclerosis. Clin Rep (Jap) 17 (1983) 153-162
52. Ikeda T. Clinical trial of YC-93 (nicardipine HCl) in patients with cerebral vascular disorders and cerebral blood flow disturbances. Clin Rep (Jap) 17 (1983) 263-277
53. Iwabuchi S. Effects and safety of nicardipine hydrochloride in patients with higher cerebral dysfunction. Med Consult New Remed (Jap) 24 (1987) 169
54. De Cabo J.P. Estudio clìnico de un derivado piridìnico nitrofenilado, la nicardipina, como agente vasodilatator cerebral. Rev Esp Geriatr Gerontol 19 (1984) 311-315
55. Vintrò Molins C., and Viaplana Màs J.M. Ensayo clìnico a doble ciego parallelo de nicardipina frente a placebo en pacientes con insuficiencia vascular cerebral crònica. Med Clin (Barc) 84 (1985) 308-311
56. Gonzàles-Elipe J., Romero J., and Lozano R. Nicardipine in the treatment of the cerebral ischemic attack sequelae. Double-blind study versus placebo. International Symposium on Calcium Antagonists (New York) (1987)
57. Spanish Group of Nicardipine Study in Vascular Dementia. An experimental, randomized, double-blind, placebo-controlled clinical trial to investigate the effect of nicardipine on cognitive function in patients with vascular dementia. Rev Neurol 15 28 (1999) 835-845
58. Gonzalez-Gonzalez J.A., and Lozano R.A. Study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin. Rev Neurol 30 (2000) 719-728
59. De Fabritiis A., Pili C., Scondotto G., and Borgatti E. Modificazioni delle resistenze vascolari cerebrali valutate mediante tecnica del doppler carotideo: effetti della nicardipina verso cinnarizina. Giorn It Angiol 5 (1985) 41-59
60. Puccinelli F., Pieraccini F., Tomei G.P., and Gargiulo L. L' ipertensione arteriosa nella fase riabilitativa dell' ictus cerebrale. Clin Ther 130 (1989) 29-35
61. Scarzella L., and Bergamasco B. La nicardipina nella terapia dell' ipertensione arteriosa dell' anziano affetto da sindrome psico-organica. Clin Ther 130 (1989) 171-178
62. Weir B. Calcium antagonist, cerebral ischemia and vasospasm. Can J Neurol Sci 11 (1984) 239-246
63. Denolle T., Sassano P., Allainc H., Bentue'-Ferrerc D., Bretona S., Cimarostic I., et al. Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients. Fundam. Clin. Pharmacol. 16 (2002) 527-535
64. Lopez-Arrieta J.M., and Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev (2002) CD000147
65. Pantoni L., del Ser T., Soglian A.G., Amigoni S., Spadari G., Binelli D., et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial. Stroke 36 (2005) 619-624
66. Wang J., Ho L., Chen L., Zhao Z., Zhao W., Qian X., et al. Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117 (2007) 3393-3402